These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29679258)

  • 21. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance of hepatocellular carcinoma: we must do better.
    Sherman M
    Am J Med; 2008 Feb; 121(2):89-90. PubMed ID: 18261492
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family physicians' knowledge and screening of chronic hepatitis and liver cancer.
    Ferrante JM; Winston DG; Chen PH; de la Torre AN
    Fam Med; 2008 May; 40(5):345-51. PubMed ID: 18465284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of chronic hepatitis B in severe liver disease.
    Fung J; Lai CL; Yuen MF
    World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for hepatocellular carcinoma: good enough but best yet to come.
    Amarapurkar D
    J Gastroenterol Hepatol; 2010 May; 25(5):845-6. PubMed ID: 20546433
    [No Abstract]   [Full Text] [Related]  

  • 28. An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection.
    Demir K; Akyüz F; Poyanli A; Okten A
    Turk J Gastroenterol; 2006 Sep; 17(3):203-5. PubMed ID: 16941254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mass screening for high risk group of hepatocellular carcinoma].
    Kawanishi T; Mima S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():786-90. PubMed ID: 11762057
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in Red Blood Cell Distribution Width is Associated with Liver Function Parameters and Prognosis in Patients with Chronic HBV Liver Disease.
    Kai Y; Zishu G; Shihe G; Yufeng G; Qiang Z
    Clin Lab; 2016 Nov; 62(11):2197-2202. PubMed ID: 28164679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
    Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.
    Crockett SD; Keeffe EB
    Ann Clin Microbiol Antimicrob; 2005 Sep; 4():13. PubMed ID: 16159399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cirrhosis due to hepatitis C virus].
    Trinchet JC
    Rev Prat; 2000 May; 50(10):1094-9. PubMed ID: 10905095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Kim EJ; Yeon JE; Kwon OS; Lee HN; Shin SK; Kang SH; Byun KS; Kim JH; Kwon SY; Suh SJ; Yim HJ; Kim YS; Kim JH
    Dig Dis Sci; 2017 Mar; 62(3):808-816. PubMed ID: 28035553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased risk of hepatocellular carcinoma in patients with chronic hepatitis C].
    Hallager S; Weis N
    Ugeskr Laeger; 2014 Oct; 176(41):. PubMed ID: 25331666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver biopsy and screening for cancer in hepatitis C.
    Gebo KA; Bass EB
    Am Fam Physician; 2003 Nov; 68(9):1719, 1723, 1726, 1728. PubMed ID: 14620594
    [No Abstract]   [Full Text] [Related]  

  • 37. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hepatitis B virus infection.
    McMahon BJ
    Med Clin North Am; 2014 Jan; 98(1):39-54. PubMed ID: 24266913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients.
    Lee HW; Ahn SH
    World J Gastroenterol; 2016 Oct; 22(37):8314-8321. PubMed ID: 27729738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.
    Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L
    J Clin Nurs; 2018 Jul; 27(13-14):2673-2683. PubMed ID: 29603817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.